Picture of Gaush Meditech logo

2407 Gaush Meditech Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapContrarian

Annual cashflow statement for Gaush Meditech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M
Source:PROSPECTUSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinal
fx
Preliminary
Net Income/Starting Line-138-275248155
Depreciation
Amortisation
Non-Cash Items42054139.463.7
Unusual Items
Other Non-Cash Items
Changes in Working Capital-177-97.3-114-193
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities164234249108
Capital Expenditures-28-48-45.6-81.2
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items108-88-12299.8
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities79.8-136-16818.5
Financing Cash Flow Items-86.7-42.5-46.3-33.9
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities72.83.08-190-303
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash302113-103-197